Organovo shareholders approve 2022 equity plan; Cohen and Gobel elected directors

VivoSim Labs, INC.

Stockholders approved 2022 Equity Incentive Plan with 94.35% of votes cast; 1,236,738 shares reserved.
Douglas Jay Cohen and David Gobel elected as Class II directors with votes for 1,845,765 and 1,879,778 respectively.
Mayer Hoffman McCann P.C. ratified as auditor for fiscal 2023 with 98.36% of votes cast.
Advisory vote on executive compensation approved with 92.40% of votes cast.
2021 Inducement Plan share reserve reduced from 750,000 to 51,000 shares effective October 12.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.